Appraisal Process

mLab Supply provides professional asset valuation for biotech, pharmaceutical, diagnostic, and life science companies preparing for liquidation, consignment, restructuring, or facility closure. Our valuations are grounded in real secondary-market data, not theoretical replacement costs, giving you a clear picture of what your assets are worth today.

We specialize in laboratory, analytical, automation, and medical equipment commonly used in regulated research and production environments.

Accurate Valuations Built on Market Reality

Laboratory assets don’t hold value in a vacuum. Demand shifts quickly based on manufacturer support, regulatory relevance, and industry trends. Our valuation process reflects actual resale behavior across auctions, private transactions, and consignment channels—so expectations are realistic from day one.

A proper valuation helps you:

• Avoid underpricing high-demand equipment

• Set informed reserves for auction or consignment

• Plan liquidation timelines with confidence

• Support internal reporting, auditors, and stakeholders

Industry-Specific Expertise Matters

Biotech and pharmaceutical assets require a different level of evaluation than general industrial equipment. We routinely assess systems from manufacturers such as Thermo, Tecan, ProteinSimple, Applikon, Eppendorf, Philips, and other major life science brands.

Our experience includes:

• Analytical instruments and spectrometers

• Automation and liquid handling systems

• Immunoassay and diagnostic platforms

• Bioprocessing and upstream/downstream equipment

• Lab accessories, components, and surplus inventory

We understand how configuration, condition, software licensing, and service status affect value—details that generic appraisers often overlook.

Our Asset Evaluation Process

Each engagement starts with a detailed review of your inventory. Assets are evaluated individually, considering:

• Manufacturer, model, and configuration

• Operational condition and completeness

• Market demand and resale velocity

• Age, serviceability, and parts availability

When applicable, we also account for bundled value, large-lot efficiencies, and strategic grouping to maximize total recovery.

Maximizing Recovery Value

Clear documentation makes a measurable difference. Service records, upgrade history, usage context, and original purchase data all improve buyer confidence and final pricing. We work with your team to identify value drivers and ensure nothing is overlooked.

Our goal isn’t just to assign a number—it’s to position your assets for the strongest possible outcome.

From Valuation to Execution

For clients moving forward with auction or consignment, we help bridge the gap between appraisal and sale. That includes guidance on:

• Sales channel selection

• Reserve pricing strategy

• Asset presentation and positioning

• Buyer targeting within the life sciences market

This end-to-end understanding helps reduce delays, uncertainty, and unnecessary value erosion.

A Practical, Professional Approach

Asset liquidation in biotech and pharma often happens under time pressure. Our process is designed to be efficient, transparent, and defensible—supporting internal decision-making while protecting asset value.

If you’re planning a lab closure, downsizing, or equipment divestment, mLab Supply offers valuation services built specifically for the realities of the life sciences market.